Market Overview

UPDATE: Deutsche Bank Initiates Coverage on Gen-Probe at Buy


According to Deutsche Bank, Gen-Probe (NASDAQ: GPRO) coverage is initiated at Buy.

Deutsche Bank said that GPRO is a leading player in the $4.5+ Bn MDx market, with a premier women's health and blood screening franchise. “Given our expectations for new product momentum to drive low double digit rev growth in the MT, we rate GPRO shares a Buy with a $70.50 PT.”

Gen-Probe closed yesterday at $56.30.

Posted-In: Deutsche BankAnalyst Color Initiation Analyst Ratings


Related Articles (GPRO-NLT2012)

View Comments and Join the Discussion!